Loading…

Synthesis and anti-tubercular activity of a series of 2-sulfonamido/trifluoromethyl-6-substituted imidazo[2,1- b]-1,3,4-thiadiazole derivatives

[Display omitted] A series of 2-sulfonamido/trifluoromethyl-6-(4′-substituted aryl/heteroaryl)imidazo[2,1- b]-1,3,4-thiadiazole derivatives ( II) have been synthesized by reaction of 2-amino-5-sulfonamido/trifluoromethyl-1,3,4-thiadiazoles and an appropriate α-haloaryl/heteroaryl ketones. Further 5-...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry 2004-11, Vol.12 (21), p.5651-5659
Main Authors: Gadad, Andanappa K., Noolvi, Malleshappa N., Karpoormath, Rajshekhar V.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] A series of 2-sulfonamido/trifluoromethyl-6-(4′-substituted aryl/heteroaryl)imidazo[2,1- b]-1,3,4-thiadiazole derivatives ( II) have been synthesized by reaction of 2-amino-5-sulfonamido/trifluoromethyl-1,3,4-thiadiazoles and an appropriate α-haloaryl/heteroaryl ketones. Further 5-bromo ( III), 5-thiocyanato ( IV), 5-gaunylhydrazone ( V) derivatives were synthesized in order to study the effect of these substituents on biological activity. Structures of these compounds were established by IR, 1H NMR, 13C NMR, Mass and HRMS. The selected compounds were evaluated for their preliminary in vitro anti-tuberculosis activity against Mycobacterium tuberculosis H37Rv strain using radiometric BACTEC and broth dilution assay methods. The results show that compounds 5, 7, 8, 10 and 12 exhibited moderate to good anti-tubercular activity with percentage inhibition of 29, 43, 58, 31 and 41, respectively, at a MIC of >6.25 μg/mL. Compound 18 showed a MIC of 20 μg/mL.
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2004.07.060